Douglas Gordon

Atai Inks Largest Fundraise In Sector History With $157M Series D Psychedelics and mental health company Atai Life Sciences has raised $157 million in venture capital. The Series D funding round is being touted as the psychedelics sector’s largest to date. Christian Angermayer, who founded...

Silo Wellness, an Oregon-based psychedelics company, announced the closing of its reverse take-over with FlyOverture Equity Inc., resulting in the listing of its stock on the Canadian Stock Exchange under the symbol 'SILO,' starting Friday. The company recently closed a round of $5 million...

Boston Suburbs Look To Decriminalize Natural Psychedelics Two Boston suburbs are the latest U.S. jurisdictions to eliminate penalties on the possession and cultivation of entheogenic plants and fungi. That includes psilocybin mushrooms, ayahuasca, the peyote cacti and the iboga...